Deployment-Oriented Evaluation of Healthcare Reimbursement Cost Prediction
PDF
PDF

How to Cite

Ouadi, Hayat, Ilhame El Farissi, and Ilham Slimani. 2026. “Deployment-Oriented Evaluation of Healthcare Reimbursement Cost Prediction”. Journal of Trends in Computer Science and Smart Technology 8 (2): 347-67. https://doi.org/10.36548/jtcsst.2026.2.008.

Keywords

Explainable AI
Healthcare Cost Prediction
Feature Importance Analysis
Deployment Feasibility
Stability Interpretability Trade-Off

Abstract

The use of healthcare cost prediction models to assist with resource allocation and risk management is on the rise, but their use is limited by the requirement for reliable, easily interpretable explanations. Although there are multiple methods of providing these explanations, their operational use in healthcare settings remains inadequately evaluated. This research analyses four of the available explainable models (i.e., Permutation Feature Importance, Tree Importance, Local Interpretable Model Explanations, and Shapley-based explanations) using a Random Forest healthcare cost prediction model developed on a real-world dataset (comprising 2,302 aggregated patient segments and 54 features) with a coefficient of determination of 0.9957. The analysis used three criteria that are critical to the deployment of these models: steadiness of explanation under data perturbation, correspondence of feature importance across methods, and computational latency. Results show that each of the global explainable models has relatively high steadiness and relatively low latency, making them applicable for real time and regulatory use; however, the local explainable models provide more intuitive instance-level explanations at the expense of lower steadiness and greater computational demands. A tiered deployment framework for method selection is proposed based on these results as guidance for selecting methods based on clinical, regulatory, and operational needs. This research provides insight into the practical use of explainable healthcare cost prediction systems within real-world environments.

References

  1. Kallestrup-Lamb, Malene, Alexander OK Marin, Seetha Menon, and Jes Søgaard. "Aging Populations and Expenditures on Health." The Journal of the Economics of Ageing 29 (2024): 100518.
  2. Marchandot, Benjamin, and Olivier Morel. "The Financialization of Healthcare in France: Trends and implications." Public Health in Practice 9 (2025): 100620.
  3. Vollmer, Sebastian, Bilal A. Mateen, Gergo Bohner, Franz J. Király, Rayid Ghani, Pall Jonsson, Sarah Cumbers et al. "Machine Learning and AI Research for Patient Benefit: 20 Critical Questions on Transparency, Replicability, Ethics and Effectiveness." arXiv preprint arXiv:1812.10404 (2018).
  4. Regulation, Protection. "Regulation (EU) 2016/679 of the European Parliament and of the Council." Regulation (eu) 679, no. 2016 (2016): 10-3.
  5. Amann, Julia, Alessandro Blasimme, Effy Vayena, Dietmar Frey, Vince I. Madai, and Precise4Q Consortium. "Explainability for Artificial Intelligence in Healthcare: A Multidisciplinary Perspective." BMC medical informatics and decision making 20, no. 1 (2020): 310.
  6. Joly, Nurzahan Akter, and Abu Shamim Mohammad Arif. "Permutation Feature Importance-Based Cardiovascular Disease (Cvd) Prediction Using Ann." In International Conference on Big Data, IoT and Machine Learning, Singapore: Springer Nature Singapore, 2023, 1039-1053.
  7. Pfeifer, Bastian, and Michael G. Schimek. "Improving the Reliability of Tree-Based Feature Importance via Consensus Signals." In International Meeting on Computational Intelligence Methods for Bioinformatics and Biostatistics, Cham: Springer Nature Switzerland, 2023, 212-225.
  8. K. Bechoua, A. Eddine DIB, H. Haouassi and H. Rahab, "P-LIME: PSO-based Local Interpretable Model-Agnostic Explanations Approach for More Reliable AI Explanations," in Journal of Communications Software and Systems, vol. 21, no. 3, July 2025, 327-337.
  9. Brandsaeter, Andreas, and Ingrid K. Glad. "XAI in Hindsight: Shapley Values for Explaining Prediction Accuracy." Expert Systems with Applications 273 (2025): 126845.
  10. Hettikankanamage, Nadeesha, Niusha Shafiabady, Fiona Chatteur, Robert MX Wu, Fareed Ud Din, and Jianlong Zhou. "eXplainable Artificial Intelligence (XAI): A Systematic Review for Unveiling the Black Box Models and their Relevance to Biomedical Imaging and Sensing." Sensors (Basel, Switzerland) 25, no. 21 (2025): 6649.
  11. Lv, Zhibin, Hui Ding, Lei Wang, and Quan Zou. "A Convolutional Neural Network Using Dinucleotide One-Hot Encoder for Identifying DNA N6-Methyladenine Sites in the Rice Genome." Neurocomputing 422 (2021): 214-221.
  12. Berggren, Mathias. "Coefficients of Determination Measured on the Same Scale as the Outcome: Alternatives to R² that Use Standard Deviations Instead of Explained Variance." Psychological methods (2024).
  13. ameli.fr - Open Data - Download. https://open-data-assurance-maladie.ameli.fr/depenses/download.php?Dir_Rep=Open_DAMIR&Annee=2024.
  14. Sedgwick, Philip, “Log Transformation of Data.” BMJ 345, (2012): e6727–e6727. https://doi.org/10.1136/bmj.e6727.
  15. Kim, Yunna, and Heasoo Hwang. "Approximate Consistent Weighted Sampling for Efficient Top-K Search." International Journal of Innovative Computing, Information and Control 16, no. 3 (2020): 1125-1132.
  16. Poreddy, Chandramohan Reddy, Ching-Hsien Hsu, and Ayesha Sadiqqa. "Serverless Computing at the Edge: Evaluating Execution Models and Latency Performance." In International Symposium on Pervasive Systems, Algorithms and Networks, Singapore: Springer Nature Singapore, 2025, 31-41.
  17. Koo, Terry K., and Mae Y. Li. "A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research." Journal of chiropractic medicine 15, no. 2 (2016): 155-163.
  18. Ganguly, Rita, and Dharmpal Singh. "Explainable Artificial Intelligence (XAI) for the Prediction of Diabetes Management: An Ensemble Approach." International Journal of Advanced Computer Science and Applications 14, no. 7 (2023).
  19. FDA, US. "Artificial Intelligence in Software as a Medical Device." US Food & Drug Administration-Center for Devices & Radiological Health (2025).
  20. Regulation, General Data Protection. "Art. 22 GDPR. Automated Individual Decision-Making, Including Profiling." Intersoft Consulting 2 (2020).
  21. Bos, Gert, and Timothy Joiner. "ISO 13485: 2016—Medical Devices—Quality Management Systems—Requirements for Regulatory Purposes." In Medical Regulatory Affairs, pp. 167-188. Jenny Stanford Publishing, 2025.
  22. Chen, Tianqi, Guestrin, Carlos, “XGBoost: A Scalable Tree Boosting System.” Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (2016): 785–94.
  23. Kumar, Deepak, Brijesh Bakariya, Chaman Verma, and Zoltan Illes. "CARE-Cirrhosis: A Multi-Level Explainability Framework Integrating Predictive Modeling and Personalized Clinical Recommendation in Cirrhosis Care." Intelligent Pharmacy (2025).